IL2 and ovarian carcinoma: We explored the efficacy of vvDD-IL-2-RG in other tumour models, including ovarian cancer (ID8), Lewis lung cancer (LLC) and another colon cancer (CT26) with similar results (Supplemental Fig. 9a–c).